ArticleClinical rheumatology2025
Cumulative atherogenic index of plasma exposure and cardiovascular disease risk: the mediating role of frailty in a Chinese middle-aged and elderly population.
Article in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtherosclerosis have been implicated in cardiovascular disease (CVD) risks, and whether frailty played a mediating role in this association was unclear.
objectivesThis study aimed to assess the associations of cumulative atherosclerosis index of plasma (CumAIP) exposure with incidence of CVD and evaluate the mediating role of frailty.
methodsThe study analyzed data from the China Health and Retirement Longitudinal Study (CHARLS) cohort. Triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C) were extracted to calculate the CumAIP. Frailty was assessed using the frailty index (FI). CVD events were confirmed based on medical history. Cox proportional hazards, linear regression, and restricted cubic spline (RCS) models were employed, along with mediation analysis.
resultsIncreased atherosclerosis was associated with increased risks of CVD. In the fully adjusted Cox model, compared to the CumAIP Q1 group, the HR and 95% confidence intervals (CI) of the Q3-Q4 groups in model 3 were 1.320 (95% CI 1.104-1.579) and 1.396 (95% CI 1.164-1.675), respectively. The CumAIP level demonstrated a positive association with frailty, with β (95% CI) of 0.016 (95% CI 0.003-0.010) in response to per 0.1 increment in CumAIP. The frailty mediated the association between atherosclerosis and CVD risk. The proportions of mediation were 11.81% between CumAIP and CVD. Subgroup and sensitivity analyses confirmed the robustness of these findings.
conclusionsAtherosclerosis was linked to increased risks of CVD. The frailty partially mediated the association between atherosclerosis and CVD. These results highlighted the significance of interventions targeting atherosclerosis and frailty in CVD prevention and management. Key Points • This study found a significant association between higher CumAIP levels and increased CVD risk, highlighting the impact of long-term lipid abnormalities on cardiovascular health. • Frailty played as a partial mediator in the link between CumAIP and CVD, highlighting its importance in the progression from atherosclerosis to CVD.
Indexed as
Identifiers
41071474What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.